THE WOODLANDS, Texas--(BUSINESS WIRE)--The US Oncology Network (The Network), a leading organization of independent, community-based practices dedicated to advancing local cancer care and better patient outcomes, announced today that Illinois CancerCare (ILCC) has joined The Network, effective Sept.

德克萨斯州伍德兰市——（商业新闻短讯）——美国肿瘤网络（THE Network）是一家致力于推进当地癌症护理和改善患者预后的独立社区实践的领先组织，今天宣布伊利诺伊州癌症护理（ILCC）已加入该网络，自9月1日起生效。

1, 2024. The practice is the predominant oncology provider throughout central Illinois. By adding ILCC to The Network, the organization continues its ongoing growth trajectory by expanding its presence into central Illinois. The practice also gains many benefits, as it strengthens its independence and enhances its ability to provide convenient access in local communities to some of the most advanced cancer treatments in the world..

12024年。该机构是整个伊利诺伊州中部的主要肿瘤学提供者。通过将ILCC添加到网络中，该组织将其业务扩展到伊利诺伊州中部，从而继续其持续的增长轨迹。这种做法也获得了许多好处，因为它增强了它的独立性，增强了它在当地社区方便获得世界上一些最先进癌症治疗的能力。。

“Illinois CancerCare is a highly successful practice that has provided superior cancer care to thousands of patients across central Illinois for nearly five decades,” said Devon Womack, president, The US Oncology Network. “The practice has a long tradition and deep belief in bringing novel clinical trials and advanced care to rural communities, a huge undertaking that offers tremendous benefits to patients.

美国肿瘤学网络总裁德文·沃马克（DevonWomack）表示：“伊利诺伊州癌症护理是一项非常成功的实践，近50年来，它为伊利诺伊州中部的数千名患者提供了优质的癌症护理。该实践有着悠久的传统和深厚的信念，可以为农村社区带来新颖的临床试验和先进的护理，这是一项为患者带来巨大利益的巨大事业。

It is a privilege to have these accomplished, dedicated physicians join us as we collaborate to make advancements in cancer care conveniently available to patients in their local communities.”.

很荣幸有这些有成就、有奉献精神的医生加入我们，我们合作使当地社区的患者能够方便地获得癌症护理方面的进步。”。

Founded in 1977, Illinois CancerCare is a comprehensive practice offering integrated care to patients with cancer and blood diseases. The practice provides medical oncology, diagnostic tests, laboratory services, targeted, biological, and hormonal therapies, supportive care services, and genetic counseling and testing, as well as cutting-edge clinical trials.

伊利诺伊州癌症护理公司成立于1977年，是一家为癌症和血液疾病患者提供综合护理的综合性机构。该机构提供医学肿瘤学、诊断测试、实验室服务、靶向、生物和激素治疗、支持性护理服务、遗传咨询和测试以及尖端临床试验。

With more than 500 full-and part-time staff, ILCC has 21 physicians, 37 advanced practice providers (APPs), and nearly 100 nurses, 40% of whom are Oncology Certified. Fourteen clinic locations enable patients across central and western Illinois to receive superior care and advanced treatments within an hour from home, eliminating the burden of long travel that can make cancer care even more challenging..

ILCC拥有500多名全职和兼职员工，拥有21名医生，37名高级实践提供者（APP）和近100名护士，其中40%是肿瘤学认证的。伊利诺伊州中西部的十四个诊所使患者能够在离家一小时内接受优质护理和高级治疗，从而消除了长途旅行的负担，这可能会使癌症护理更具挑战性。。

Illinois CancerCare has a long and proud history of offering advanced clinical trials to patients, as clinical research has been a core value and fundamental pillar of the practice since its beginnings. The practice’s award-winning research program has enrolled more than 13,000 patients in clinical trials over the last 40 years..

伊利诺伊州癌症护理公司（Illinois CancerCare）在为患者提供先进的临床试验方面有着悠久而引以为傲的历史，因为临床研究自成立以来一直是该实践的核心价值和基本支柱。该机构屡获殊荣的研究项目在过去40年中已经招募了13000多名患者进行临床试验。。

'I am thrilled Illinois CancerCare is joining The Network, as it allows us to access unparalleled resources in precision medicine, clinical research, and operational expertise,” said Paul Fishkin, MD, practice president, ILCC. “This collaboration enhances our ability to deliver personalized, cutting-edge treatments and supports our expansion into new geographies.

ILCC执业总裁保罗·菲什金（PaulFishkin）医学博士说：“我很高兴伊利诺伊州癌症护理公司（Illinois CancerCare）加入该网络，因为它使我们能够获得精准医学、临床研究和运营专业知识方面无与伦比的资源。”。“这种合作增强了我们提供个性化尖端治疗的能力，并支持我们向新地区的扩张。

It signifies our commitment to adapting in a rapidly changing landscape and provides robust support systems for our next generation of leaders.'.

它意味着我们致力于适应快速变化的环境，并为我们的下一代领导人提供强大的支持系统。”。

As the business of oncology has grown extremely complex, independent practices like ILCC have found it increasingly difficult to thrive. As a member of The Network, Illinois CancerCare will now have access to the vast resources, industry-leading technologies, and deep expertise of The Network, empowering the practice with innovative solutions to support high-quality patient care, efficient drug management, and revenue cycle optimization.

随着肿瘤学业务变得极其复杂，像ILCC这样的独立实践发现越来越难以蓬勃发展。作为该网络的成员，伊利诺伊州癌症护理公司（Illinois CancerCare）现在将获得该网络的大量资源、业界领先的技术和深厚的专业知识，为该实践提供创新解决方案，以支持高质量的患者护理、高效的药物管理和收入周期优化。

The practice’s clinical staff can also collaborate with their colleagues across The Network, drawing on the collective knowledge and experience of more than 2,600 independent providers across the U.S..

该机构的临床工作人员还可以通过网络与同事合作，利用美国2600多家独立提供商的集体知识和经验。。

The Network is supported by McKesson Corporation, an industry leader in value-based care with a comprehensive suite of solutions and services that enables practices to succeed in the evolving healthcare landscape. From access to Ontada’s cutting-edge technologies enabling enhanced patient referral, patient intake, and provider workflow as well as simplified genomic test ordering and result capture, to increased access to innovative clinical trials through McKesson’s joint venture with Sarah Cannon Research Institute, McKesson’s unapparelled oncology portfolio helps community-based practices like ILCC thrive, so they can best care for their patients..

该网络由McKesson Corporation提供支持，McKesson Corporation是基于价值的护理领域的行业领导者，拥有一套全面的解决方案和服务，使实践能够在不断发展的医疗保健领域取得成功。从获得Ontada的尖端技术，增强患者转诊，患者摄入和提供者工作流程，简化基因组测试排序和结果捕获，到通过麦凯森与莎拉·坎农研究所的合资企业增加创新临床试验的机会，麦凯森未受欢迎的肿瘤学组合有助于ILCC等社区实践的蓬勃发展，从而为患者提供最佳护理。。

The physicians and APPs of ILCC are among more than 400 new providers who have joined The Network within the last 18 months. This continual growth is greatly increasing the availability of advanced cancer care in local communities from strong, viable, and independent practices.

ILCC的医生和应用程序是过去18个月内加入该网络的400多家新提供商之一。这种持续的增长大大增加了当地社区从强大，可行和独立的实践中获得先进癌症护理的可能性。

About Illinois CancerCare

关于伊利诺伊州癌症护理

Illinois CancerCare is one of the largest practices in Illinois that treats patients with cancer and blood diseases. It provides state-of-the-art treatments to its patients for these complex diseases by staying at the leading-edge of clinical research. Illinois CancerCare is central Illinois’ largest network of cancer care specialists with approximately 100 open clinical cancer research trials being conducted at any given time.

伊利诺伊州癌症护理（Illinois CancerCare）是伊利诺伊州治疗癌症和血液疾病患者的最大实践之一。它通过保持临床研究的领先地位，为这些复杂疾病的患者提供最先进的治疗方法。伊利诺伊州癌症护理中心（Illinois CancerCare）是伊利诺伊州中部最大的癌症护理专家网络，在任何给定时间都在进行大约100项开放的临床癌症研究试验。

The group has been recognized by the Quality Oncology Practice Initiative Certification Program for outpatient hematology-oncology practices that meet the highest national standards for quality cancer care. Illinois CancerCare has 21 physicians, 37 APPs, and more than 500 staff members. The practice serves patients at 14 clinic locations throughout central and western Illinois including Bloomington/Normal, Canton, Carthage, Dixon, Eureka, Galesburg, Kewanee, Macomb, Ottawa, Pekin, Peoria, Peru, Princeton, and Washington..

该集团已获得质量肿瘤学实践倡议认证计划的认可，该计划针对门诊血液肿瘤学实践，符合国家最高质量癌症护理标准。伊利诺伊州CancerCare拥有21名医生，37个应用程序和500多名员工。该诊所在伊利诺伊州中西部的14个诊所为患者提供服务，包括布卢明顿/诺曼（Bloomington/Normal）、坎顿（Canton）、迦太基（Carthage）、迪克逊（Dixon）、尤里卡（Eureka）、加列斯堡（Galesburg）、基瓦尼（Kewanee）、马库姆（Macomb）、渥太华（Ottawa）、佩金（Pekin）、皮奥里亚（Peoria）、秘鲁。。

About The US Oncology Network

关于美国肿瘤学网络

Every day, The US Oncology Network (The Network) helps more than 2,600 independent providers deliver value-based, integrated care to patients — close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes.

每天，美国肿瘤学网络（The Network）帮助2600多家独立提供者为患者提供基于价值的综合护理-离家不远。通过该网络，这些独立的医生聚集在一起，形成一个共享专业知识和资源的社区，致力于推进当地癌症护理并提供更好的患者结果。

The Network provides practices with access to coordinated resources, best business practices, and the experience, infrastructure, and support of McKesson Corporation. This collaboration allows the providers in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices.

该网络为实践提供了获得协调资源、最佳商业实践以及McKesson Corporation的经验、基础设施和支持的途径。这种合作使网络中的提供者能够专注于患者的健康，而McKesson则专注于其实践的健康。

The Network is committed to the success of independent practices, everywhere..

该网络致力于在任何地方取得独立实践的成功。。

About McKesson Oncology and Specialty Solutions

关于McKesson肿瘤学和专业解决方案

It’s an unprecedented time for patients living with cancer as life sciences companies race to create new, cutting-edge therapies. With cancer care becoming more targeted, providers, life sciences companies, and payers face a multitude of challenges and complexity in the development of new treatments and making them accessible to patients in need.

对于癌症患者来说，这是一个前所未有的时代，因为生命科学公司正在争相创造新的尖端疗法。随着癌症护理越来越有针对性，提供者，生命科学公司和付款人在开发新疗法并使有需要的患者能够获得这些疗法方面面临着众多挑战和复杂性。

At McKesson, our unmatched portfolio of oncology businesses and partners provide research, insights, technologies, and services that are helping to address these hurdles and improve cancer and specialty care..

在麦凯森，我们无与伦比的肿瘤学业务和合作伙伴组合提供研究、见解、技术和服务，帮助解决这些障碍，改善癌症和专科护理。。

McKesson is fueling discovery by helping patients participate in cutting-edge clinical trials closer to home through its joint venture with Sarah Cannon Research Institute.

麦凯森通过与莎拉·坎农研究所（SarahCannonResearch Institute）的合资企业，帮助患者在离家较近的地方参与尖端临床试验，从而推动了这一发现。

The US Oncology Network and McKesson Provider Solutions are advancing specialty care and high-quality cancer care in the communities where patients live by supporting the practices of thousands of independent, community-based providers.

美国肿瘤学网络和McKesson提供者解决方案通过支持数千名独立的社区提供者的实践，正在患者居住的社区推进专科护理和高质量的癌症护理。

Ontada®, a McKesson business dedicated to oncology, generates real-world data (RWD) and real-world evidence (RWE), and provides clinical education and provider technology to inform and improve cancer care.

Ontada®是一家专注于肿瘤学的McKesson企业，它可以生成真实世界的数据（RWD）和真实世界的证据（RWE），并提供临床教育和提供者技术，以告知和改善癌症护理。

As a leading distributor of oncology and specialty medicines, we are ensuring medicines make their way to those who are counting on them.

作为肿瘤学和特种药物的领先分销商，我们正在确保药物能够流向那些依赖它们的人。

And through CoverMyMeds, Biologics by McKesson, and GPO services, our work continues to help patients access, afford, and adhere to their medicines.

通过CoverMyMeds、McKesson的生物制剂和GPO服务，我们的工作继续帮助患者获得、负担和坚持他们的药物。